203 studies found for:    Open Studies | "Heparin"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Heparin"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting A Comparison of Dilute Versus Concentrated Heparin for CRRT Anticoagulation
Conditions: Acute Kidney Injury;   Acute Renal Failure;   Heart Failure
Interventions: Drug: Dilute unfractionated heparin;   Drug: Standard concentration unfractionated heparin
2 Unknown  DEDICA (Dose of HEparin During Coronary Angioplasty) Trial
Conditions: Stable Angina;   Angina, Unstable;   Non-ST Elevation (NSTEMI) Myocardial Infarction
Interventions: Drug: Low-dose heparin;   Drug: Standard dose heparin
3 Recruiting Balloon Aortic Valvuloplasty Performed Without Heparin to Decrease Vascular and Bleeding Complications of the Procedure
Condition: Aortic Stenosis, Non-rheumatic
Interventions: Drug: Heparin;   Drug: NaCl
4 Not yet recruiting Aneurysmal Subarachnoid Hemorrhage Trial RandOmizing Heparin
Conditions: Aneurysmal Subarachnoid Hemorrhage;   Neurobehavioral Manifestations;   Vasospasm, Intracranial;   Intracranial Aneurysm;   Heparin-induced Thrombocytopenia Type II
Intervention: Drug: Continuous Low-Dose Intravenous Unfractionated Heparin Infusion (14 days)
5 Recruiting Optimized Heparin Regimen in Vascular Surgery
Condition: Peripheral Revascularisation
Interventions: Procedure: ACT;   Procedure: TEG;   Procedure: Ankle-brachial index;   Procedure: Toe-brachial index;   Drug: Heparin
6 Recruiting Randomized Comparison of Continuous and Intermittent Heparin Infusion During Catheter Ablation of Atrial Fibrillation
Condition: Coagulation; Intravascular
Interventions: Drug: Continuous heparin infusion;   Drug: Intermittent heparin infusion
7 Recruiting High (100IU/Kg) Versus Standard (50IU/Kg) Heparin Dose for Prevention of Forearm Artery Occlusion
Condition: Coronary Angiography
Interventions: Drug: High dose of Unfractionated Heparin;   Drug: Standard dose of Unfractionated heparin
8 Unknown  Effects of Aspirin and Low Molecular Weight Heparin in IVF Outcome.
Condition: To Investigate the Effects of Low Dose Aspirin and Low Molecular Weight Heparin in IVF Out Come
Interventions: Drug: Low molecular weight heparin;   Drug: Low dose aspirin;   Drug: Heparin & aspirin;   Other: NaCl
9 Recruiting Bivalirudin vs Heparin in NSTEMI and STEMI in Patients on Modern Antiplatelet Therapy in SWEDEHEART
Conditions: ST-segment Elevation Myocardial Infarction;   Non ST-segment Elevation Myocardial Infarction
Interventions: Drug: bivalirudin;   Drug: Heparin
10 Recruiting Study of the Efficacy, Safety and Tolerability of Low Molecular Weight Heparin vs. Unfractionated Heparin in Stroke
Condition: Embolic Stroke
Interventions: Drug: Enoxaparin;   Drug: Heparin
11 Unknown  OPG and RANKL Plasma Level After Administration of Unfractionated Heparin (UFH) and Low-Molecular-Weight Heparin (LMWH) in Hemodialysis
Conditions: Renal Failure;   Hemodialysis
Interventions: Drug: law molecular weigth heparin;   Drug: unfractioned heparin
12 Recruiting Heparin for the Treatment of Burn Wound Pain
Condition: Second Degree Burns
Interventions: Drug: Polyfax & Lignocain gel or silvazine cream;   Drug: Topical Heparin;   Drug: Tramadol
13 Unknown  Safety and Efficacy of Lean Body Weight-based IV Heparin Dosing in Obese/Morbidly Obese Patients
Conditions: Obesity;   Morbid Obesity;   Venous Thromboembolism;   Atrial Fibrillation;   Angina;   Chest Pain
Intervention: Drug: Lean Body Weight-based heparin dose
14 Unknown  Use of Tinzaparin for Anticoagulation in Hemodialysis
Condition: Kidney Failure, Chronic
Interventions: Drug: Tinzaparin;   Drug: Unfractionated Heparin;   Drug: Placebo (for Tinzaparin);   Drug: Placebo (for Unfractionated Heparin)
Conditions: The Primary Study Objective is to Assess the Efficacy and;   Safety of Extended 4-week Heparin Prophylaxis Compared to;   Prophylaxis Given for 8±2 Days After Planned Laparoscopic;   Surgery for Colorectal Cancer.;   The Clinical Benefit Will be Evaluated as the Difference in;   the Incidence of VTE or VTE-related Death Occurring Within 30 Days;   From Surgery in the Two Study Groups.
Intervention: Drug: Heparin, Low-Molecular-Weight
16 Unknown  Aspirin, Heparin and Miscarriage
Conditions: Pregnancy;   Miscarriage
Interventions: Drug: Aspirin;   Drug: Heparin
17 Recruiting Safety and Efficacy of Heparin and Nadroparin in the Acute Phase of Ischemic Stroke
Condition: Acute Ischemic Stroke
Interventions: Drug: Heparin;   Drug: Nadroparin;   Drug: Placebo
18 Unknown  Study of Clinical Non-inferiority of Actparin® (Laboratorio Bergamo) Compared to Heparin Sodium (APP Pharmaceuticals), in Patients With Chronic Renal Failure
Condition: Chronic Renal Failure
Intervention: Biological: heparin sodium
19 Recruiting Propaten Randomized Investigation on Cost-benefit and Efficacy
Condition: End-stage Renal Disease
Interventions: Device: Heparin-bonded vascular access graft;   Device: Conventional ePTFE hemodialysis graft
20 Unknown  Efficacy and Safety of Sodium Heparin in Patients Submitted to Heart Surgery Using Bypass
Condition: Cardiac Surgery
Interventions: Drug: heparin sodium - Bergamo;   Drug: heparin sodium - APP

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years